My Cart 0
Do not conform to the pattern of this world but be transformed by the renewing of your mind. Then you will be able to test and approve what God’s will is—his good, pleasing, and perfect will.
Romans 12:2-4 NIV
META HEALTH LIMITED
Meta Health Limited (META), formerly known as Metal Component Engineering Limited, was founded in 1987 in Singapore. With consistent focus on quality and engineering innovation, META has expanded its customer base by serving MNC (Multi-National-Corporation), EMS (Electronic Manufacturing Services), and SME (Small-Medium-Enterprise) globally.
META has recently diversified into healthcare technology and services with investment into Gainhealth Pte. Ltd., a direct-to-consumer and high-growth omnichannel health and wellness platform. Their healthcare segments now include (1) Primary & Homecare, (2) Central Pharmacy, (3) Clinical Nutrition distribution and (4) Infrastructure as a service (where they help medical institutes digitalise their operations)
Recent Developments
- 10 Oct 2024 General Announcement::Entry Into Non-binding Term Sheet Relating to Potential Acquisition
- 10 Sep 2024 General Announcement::Update on Receipt of Originating Claim - Agreement to Settlement
- 08 Aug 2024 Financial Statements and Related Announcement::Half Yearly Results
- 01 Aug 2024 Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Interest of Director - Sim Mong Keang
- 22 Jul 2024 General Announcement::Reconstitution of Board & Board Committees
- 22 Jul 2024 Change - Announcement of Appointment::Appointment of Independent Non-Executive Director - Mr Sim Mong Keang
- 22 Jul 2024 WD::General Announcement::Reconstitution of Board & Board Committees
- 22 Jul 2024 WD::Change - Announcement of Appointment::Appointment of Independent Non-Executive Director - Mr Sim Mong Keang
- 22 Jul 2024 General Announcement::Reconstitution of Board & Board Committees
- 22 Jul 2024 Change - Announcement of Appointment::Appointment of Independent Non-Executive Director - Mr Sim Mong Keang
- 02 Jul 2024 Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Changes in Interest of Substantial Shareholders - Blue Ocean Capital Partners & Estate of Lin Wei
- 27 Jun 2024 Change - Change in Corporate Information::CHANGE OF COMPANY SECRETARY
- 05 Jun 2024 General Announcement::RECEIPT OF ORIGINATING CLAIM
- 28 May 2024 General Announcement::MINUTES OF ANNUAL GENERAL MEETING HELD ON 29 APRIL 2024
- 21 May 2024 General Announcement::UPDATES ON OUT-OF-COURT SETTLEMENT INVOLVING WHOLLY-OWNED SUBSIDIARIES
- 30 Apr 2024 Annual Reports and Related Documents::
- 30 Apr 2024 General Announcement::REQUEST FOR LIFTING OF TRADING HALT - SPONSOR'S STATEMENT
- 30 Apr 2024 Request for Lifting of Trading Halt::REQUEST FOR LIFTING OF TRADING HALT
- 30 Apr 2024 General Announcement::RECONSTITUTION OF THE BOARD OF DIRECTORS
- 30 Apr 2024 Change - Announcement of Cessation::Cessation of Chairman of the Board - Dr Bernard Ng Kee Huat
Investment Merits
Proxy to the digitalization of healthcare in the region
- Central Pharmacy facilitates the delivery of medicine for likes of clinics and nursing homes to end patients
- Rising user base for E-pharmacy
- Provides platform for medical institutes looking to digitalise their operations under the IAAS segment
Clinical Nutrition Distribution to tap into the central pharmacy’s B2B network for distribution
- Distributing to over 600 repeat customers including retailers and F&B outlets, Meta Health’s distribution arm has room for further growth as it taps into its central pharmacy’s network for cross-selling opportunities
Infrastructure-as-a-service (IAAS) segment can be highly scalable and profitable
- In collaboration with other vendors including MedTel, Meta Health has successfully launched a comprehensive suite of software solutions to help medical institutes digitalise their operations without incurring heavy CAPE
In The News
- Meta Health appoints Bernard Ng as new chairman and CEO, eyes “strategic review” of existing business
- Meta-SG: Meta Health Ltd- Stock Price, Quote and News
- Meta- Health Reuters
Stock Information
(as of 02 September 2024)
| Price | Market Cap (SGDm) | Enterprise Value (SGDm) |
|---|---|---|
| SGD 0.0080 | 8.25 | 9.43 |
Key Financial Highlights
| Key Highlights | TTM (SGD) |
|---|---|
| Revenue | 1.48M |
| Net Income Available to Common | -1.96M |
| Profit Margin | 0.00% |
| Return on Assets | -6.52% |
| Return on Equity | -216.11% |
| Price/Sales (ttm) | 3.69 |
| Price/Book (mrq) | 4.26 |
| Enterprise Value/Revenue | 6.36 |
| Enterprise Value/EBITDA | -3.01 |
| Total Cash (mrq) | 1.93M |
| Total Debt/Equity (mrq) | — |
| Levered Free Cash Flow (ttm) | 1.76M |